PAM
AMRI

Panagora Asset Management’s Albany Molecular Research Inc AMRI Stock Holding History

Panagora Asset Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,315
Closed -$231K – 2501
2016
Q4 		$231K Sell
12,315
-11,421
-48% -$194K ﹤0.01% 1703
2016
Q3 		$392K Buy
23,736
+17,615
+288% +$261K ﹤0.01% 1533
2016
Q2 		$82K Hold
6,121
– – ﹤0.01% 1958
2016
Q1 		$94K Hold
6,121
– – ﹤0.01% 1874
2015
Q4 		$122K Hold
6,121
– – ﹤0.01% 1746
2015
Q3 		$107K Buy
+6,121
New +$125K ﹤0.01% 1798
2015
Q1 		– Sell
-20,768
Closed -$338K – 2420
2014
Q4 		$338K Sell
20,768
-7,019
-25% -$129K ﹤0.01% 1426
2014
Q3 		$613K Sell
27,787
-9,044
-25% -$185K ﹤0.01% 1238
2014
Q2 		$741K Sell
36,831
-34,500
-48% -$584K ﹤0.01% 1238
2014
Q1 		$1.33M Buy
71,331
+8,902
+14% +$123K 0.01% 1052
2013
Q4 		$629K Sell
62,429
-305
-0.5% -$3.69K ﹤0.01% 1312
2013
Q3 		$809K Buy
62,734
+1,251
+2% +$15.4K ﹤0.01% 1191
2013
Q2 		$730K Buy
+61,483
New +$666K ﹤0.01% 1183

Other funds holding AMRI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
WC
Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return

Panagora Asset Management's AMRI Position: Q1 2017 in Review

Panagora Asset Management sold out of Albany Molecular Research Inc (AMRI) in Q1 2017, closing a stake of 12,315 shares — an estimated $231K sold.

Panagora Asset Management first reported a position in AMRI in Q2 2013 and held it in 13 quarters. The position peaked at $1.33M in Q1 2014. 139 funds tracked by Wall St. Rank hold AMRI as of Q1 2017.

  • Panagora Asset Management reported no remaining Albany Molecular Research Inc position as of Q1 2017 after selling out during the quarter.
  • Panagora Asset Management sold 12,315 Albany Molecular Research Inc shares in Q1 2017, an estimated $231K.
  • Panagora Asset Management first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 13 quarters.
  • Panagora Asset Management's Albany Molecular Research Inc position peaked at $1.33M in Q1 2014.
  • 139 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2017.

Based on Panagora Asset Management's 13F filing for Q1 2017, filed 15 May 2017.